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Anxiety is an instinct that may have developed to promote adaptive survival by evading unnecessary 
danger. However, excessive anxiety is disruptive and can be a basic disorder of other psychiatric 
diseases such as depression. The KF-1, a ubiquitin ligase located on the endoplasmic reticulum 
(ER), may prevent excessive anxiety; kf-1−/− mice exhibit selectively elevated anxiety-like behavior 
against light or heights. It is surmised that KF-1 degrades  some target proteins, responsible for 
promoting anxiety, through the ER-associated degradation pathway, similar to Parkin in Parkinson’s 
disease (PD). Parkin, another ER-ubiquitin ligase, prevents the degeneration of dopaminergic 
neurons by degrading the target proteins responsible for PD. Molecular phylogenetic studies 
have revealed that the prototype of kf-1 appeared in the very early phase of animal evolution 
but was lost, unlike parkin, in the lineage leading up to Drosophila. Therefore, kf-1−/− mice may 
be a powerful tool for elucidating the molecular mechanisms involved in emotional regulation, 
and for screening novel anxiolytic/antidepressant compounds.
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IntroductIon
Anxiety, or learned fear, is not necessarily harm-
ful to everyday life but, rather, is a natural ability 
that may have arose to evade unnecessary dan-
gers. However, excessive anxiety is debilitating or 
disadvantageous for life as it reduces behavioral 
activities  necessary  for  adaptation.  Moreover, 
anxiety can be a core symptom of various   mental/
behavioral  disorders,  such  as  major  depres-
sive disorders,  obsessive-compulsive  disorders, 
panic disorder, adaptive disorder, post-traumatic 
stress disorder, social withdrawal disorder, and 
various phobias. Patients with anxiety/depres-
sion interpret circumstantial incidences, includ-
ing episodes, comments, and expressions, in a 
negative way. The interpretation leads individu-
als to enhanced capture or delusions caused by 
potential signs of danger. This suggests that a 
system of negative and positive regulation of the 
emotional expression may have developed under 
the evolutionary constraint. Such a system would 
be most apparent in highly social animals with 
relatively little reproduction per generation, like 
humans (Darwin, 1872). Indeed, there is evidence 
that the amygdala is responsible for the expres-
sion of anxiety or fear, and the prefrontal cor-
tex plays a role in fear extinction by regulating 
the amygdala-mediated expression of fear (see 
Bishop, 2007). Although the molecular mecha-
nisms underlying negative and positive regula-
tion of the anxiety are not fully understood, many 
genes have been reported to affect anxiety or fear 
(Chen et al., 1994; Gogos et al., 1998; Heisler et al., 
1998; Holmes et al., 2003; Miyakawa et al., 1994, 
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2003; Nakajima et al., 2008; Yamasaki et al., 2008). 
Among these, the genes related to the serotoner-
gic system are seen to be of special interest. For 
example,  human  genomic  studies  of  anxiety/
depression have focused on genes related to the 
monoaminergic neurotransmission of serotonin 
receptors  (5-HT1A)  and  transporters  (5-HTT) 
(see Levinson, 2006; Uher and McGuffin, 2008). 
Genetic studies using gene-targeting techniques 
have revealed that knockout mice lacking either 
5-ht1A or 5-htt exhibit significantly increased anx-
iety-like behaviors (Heisler et al., 1998; Holmes 
et al.,  2003).  However,  proteins  that  interact 
directly with neurotransmitters seem to func-
tion downstream, rather than upstream, of the 
serotonergic pathway.
Anxiety/depression is the most common psy-
chiatric disease seen in patients irrespective of 
nations, societies, and religions. Consequently, 
pharmaceutical  companies  have  made  exten-
sive  worldwide  efforts  to  develop  anxiolytic/
antidepressant  drugs,  particularly  serotonergic 
compounds such as selective serotonin reuptake 
inhibitor  (SSRI)  and  serotonin  noradrenalin 
reuptake inhibitor (SNRI) based on the monoam-
ine  hypothesis.  The  hypothesis  assumes  that 
the pathogenesis of depression is caused by the 
depletion of monoamines such as serotonin in 
the brain. This assumption has however not been 
proven in the last 60 years. Testing systems have 
been developed for rodents to measure behavioral 
despair and to screen   serotonergic drugs. These 
include the forced swim test and the tail suspen-
sion test. Compounds that elevate monoamine 
levels in the brain reduce the despair-like behav-
ior or immobility time of animals under fearful 
conditions (Porsolt et al., 1978; Steru et al., 1985). 
However, approximately one-third of the patients 
with anxiety/depression do not respond to the 
serotonergic drugs, suggesting that despair-like 
behavior in rodents does not precisely represent 
anxiety/depression in humans, from a pharma-
cological point of view. Therefore, it is desirable 
to have some genetic animal models that display 
excessive anxiety-like behavior specifically with-
out affecting despair-like behavior, as observed in 
the kf-1
−/− mice (Tsujimura et al., 2008), to look 
for  novel  anxiolytic/antidepressant  drugs  that 
are effective in patients who do not respond to 
serotonergic drugs.
IdentIfIcatIon and nature of Kf-1
The  gene  for  KF-1  was  originally  discovered 
in  connection  with  Alzheimer’s  disease  (AD). 
Genetic studies of familial AD (FAD) made sig-
nificant progress in 1990s. In this period, three 
genes  encoding  β-amyloid  precursor  protein, 
pressenilin-1  (PS1),  and  presenilin-2  (PS2) 
were identified as the causative genes for FAD 
(see Hashimoto-Gotoh et al., 2006; Lundkvist and 
Näslund, 2007), and two other genes were found 
expressed more frequently in the frontal cortex of 
an AD patient than a non-AD subject (Yasojima 
et al., 1997). One of the later two genes, gfap, was 
a known gene encoding glial fibrillary acidic pro-
tein, and the other was a novel gene, named kf-1. 
The kf-1 gene is expressed most prominently in 
the brain and more or less throughout the entire 
body, but least, if any, in the liver, which implies 
that kf-1 may not be a housekeeping gene. Human 
kf-1 has four exons ranging over approximately 
30 kb,  and  is  mapped  to  chromosome  2p11.2. 
The protein structure deduced from the cDNA 
sequences has revealed that human KF-1 protein 
(GenBank Acc No. BAA19739) consists of 685 
amino acids, and contains a possible leader pep-
tide (amino acid positions 1–19), two membrane-
spanning segments (326–345 and 366–380), and 
a  RING-H2  finger  motif  (621–662)  close  to 
the C-terminus (Figure 1A). KF-1-like proteins 
have been found in other animals including fish 
(Danio rerio), lancelet (Blanchistoma floridae), sea 
urchin (Strongylocentrotus purpuratus), sea anem-
one (Nematostella vectensis), and tablet animals 
(Trichoplax  adhaerens)  (Figure 1A).  Molecular 
phylogenetic studies suggest that genes for the ani-
mal and vertebral proteins may be kf-1 orthologues 
(Figures 1B,C, respectively). Unexpectedly, KF-1 
homologues do not exist in insects (Drosophila 
melanogaster) and thread worms (Caenorhabditis 
elegans, and C. briggsae), even though it is likely 
that the prototype gene appeared in the very early 
phase of animal evolution, before the separation 
of  Placozoa  and  Eumetazoa  (Miller  and  Ball, 
2008; Srivastava et al., 2008). Homologues of the 
prototype do not exist in prokaryotes, plants, or 
fungi, but are found first in one of the most primi-
tive multicellular animals, such as tablet animals 
(Schubert, 1993) (Figure 1D). The results may 
be consistent with the report based on the EST 
analysis that some genes, formerly thought to be 
vertebrate inventions, must have been present in 
the common metazoan ancestor (Kortschak et al., 
2003).  Choanoflagellates  (Monosiga  brevicollis, 
and M. ovata), supposedly one of the most closely 
related unicellular protists to animals (King et al., 
2008), do not possess kf-1 (Figure 1D).
The KF-1 protein is an E3 ubiquitin ligase 
that may modulate the cellular protein levels of 
its unknown substrate(s) (Lorick et al., 1999). 
The expression of kf-1 is also increased in the 
frontal cortex and hippocampus after chronic 
administration of SSRI in rats (Yamada et al., 
2000). Furthermore, rat kf-1 expression is elevated 
RING-H2 finger motif
A type of zinc binding domains, similar 
to RING finger motif containing  
a C3HC4 amino acid motif for binding 
to two zinc ions. RING-H2 finger  
motif contains two histidine residues  
as in C3H2C3 motif.  
Many of the RING finger domains 
function as ubiquitin ligases.Frontiers in Neuroscience  www.frontiersin.org  May 2009 |  Volume 3  |  Issue 1  |  17
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Figure 1 | Molecular phylogenetic studies of the kf-1 gene. (A) The alignment 
of KF-1 protein sequences. The sequence identities (%) given at the ends were 
obtained against human sequences minus the regions after the RING-H2 finger 
motif, namely after amino acid position 621 in human KF-1. Asterisks show the 
alignment sites used for inferring the molecular phylogenetic tree in (B). The 
two transmembrane regions of human KF-1 are indicated by ‘=’ and the RING-H2 
finger motif for zinc-binding is indicated by ‘#’. The number given at the right side 
indicates the amino acid position of the C-terminal amino acid in each line.  
The alignment positions, including gaps, are given on the top right of each row. 
Hs, Dr, Bf, Sp, Nv, and Ta denote Homo sapiens, Danio rerio, Blanchistoma 
floridae, Strongylocentrotus purpuratus, Nematostella vectensis and Trichoplax 
adhaerens, respectively. The gene identification (GI) numbers are 1945615, 
52219054, 210102052, 115660659, 156406687, and 196009364 in the respective 
species. Blast Expect values (blastp with BLOSUM62 for Matrix) of Dr, Bf, Sp, Nv, 
and Ta against Hs are E < 10−130, E = 2 × 10−130, E = 3 × 10−117, E = 3 × 10−104,  
and E = 3 × 10−57, respectively. CS denotes consensus amino acid. (continued)Frontiers in Neuroscience  www.frontiersin.org  May 2009 |  Volume 3  |  Issue 1  |  18
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after physical   antidepressant treatments, such as 
electroconvulsive therapy (Nishioka et al., 2003), 
and repetitive transcranial magnetic stimulation 
(Kudo  et al.,  2005).  This  implies  that  the  up-
regulation of kf-1 expression is associated with 
some physiological responses to antidepressant 
treatments rather than being caused by a chemi-
cal reaction to serotonergic compounds such as 
SSRIs. It was, however, not clear whether this was 
a result, cause, or coincidental side effect of anti-
depressive processes.
As a possible correlation between KF-1 and AD 
has been suggested (Yasojima et al., 1997), and as 
depression can occur early in the course of AD 
in ps1 mutation carriers unaware of their genetic 
status (Ringman et al., 2004), the first working 
hypothesis was that presenilins could be KF-1 sub-
strates in the endoplasmic reticulum (ER) associ-
ated degradation (ERAD) pathway (see Carvalho 
et al., 2006; Lorick et al., 2006). Therefore, the 
intracellular localization of KF-1 was examined 
in comparison to that of   presenilins known to be 
located on ER (Kovacs et al., 1996). The results 
have revealed that KF-1 is co-  localized with both 
PS1 and PS2 (Figures 2A,B and Tsujimura et al., 
2008), which implies that KF-1 may in fact be an 
ER-ubiquitin ligase. The co-localization of KF-1 
with other ER markers, such as Der-1 and VCP, 
has also been observed (Maruyama et al., 2008).
SelectIve expreSSIon of IncreaSed 
anxIety-lIKe behavIorS In kf-1–/– mIce
Although mouse kf-1 is expressed in many tis-
sues, particularly in the brain, the lack of kf-1 does 
not lead to any abnormalities in appearance or 
behaviors, including body weight, reproductive 
capability, exploratory locomotion, nociception, 
social behavior, motor coordination, behavioral 
despair,  spatial  working  memory,  and  context 
memory (Table 1).
The  exception  is  that  kf-1−/−  mice  display 
a  pronounced  increase  in  anxiety-like  behav-
ior in the light/dark transition test (stay time 
in  light  compartment:  p = 0.0004;  number  of 
Molecular phylogenetic tree
A diagram showing the evolutionary 
relationship or history of organisms, 
genes or proteins. It is inferred  
by a phylogentic method such as 
neighbor-joining, maximum 
parsimony, or maximum likelihood, 
based on the nucleotide or amino  
acid sequences of various species.
Figure 1 | Molecular phylogenetic studies of the kf-1 gene. (B) The molecular phylogenetic tree for animal KF-1.  
The tree is inferred by the genetic algorithm-based maximum likelihood method (Katoh et al., 2001). The evolutionary  
rate heterogeneity among the sites was taken into account by assuming Yang’s discrete gamma model (Yang, 1994)  
and an optimized shape parameter alpha of 1.93. Highly homologous sites without gap sites (404 amino acid sites)  
were selected for the comparison as indicated by asterisks in (A). The numbers at each branching node represent  
the bootstrap probability. The branching orders within the ellipse are not significant. The shaded region is expanded in (C) 
for vertebral KF-1. GI numbers are given in (A). (C) The maximum likelihood tree for vertebral KF-1, which corresponds  
to the shaded region in (B). Highly homologous sites without gap sites within the vertebrate sequences (580 amino acid 
sites; not shown) were used for tree inference. The optimized shape parameter alpha is 0.43. The numbers at the 
branching nodes are the bootstrap probabilities. GI numbers are given in (A) for H. sapiens and D. rerio, and 2058263, 
126305140, 71896439, and 20126691 for M. musculus, M. domestica, G. gallus, and X. laevis, respectively. (continued)Frontiers in Neuroscience  www.frontiersin.org  May 2009 |  Volume 3  |  Issue 1  |  19
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Figure 1 | Molecular phylogenetic studies of the kf-1 gene.  
(D) Presence/absence, generation, and transmission of kf-1 on 
the evolutionary tree of life. The tree is essentially the same as the one, 
that was previously presented (Hashimoto-Gotoh et al., 2003), with minor 
modifications and corrections except for the genes concerned. ‘?’  
with bi-arrows and two open stars or crosses denotes uncertainty  
of the precise position of generation or loss of kf 1, respectively.  
Circles or crosses represent species in which the presence or absence  
of kf-1 has been confirmed in the Gen Bank database on January 29, 2009. 
In the case of sea squirt (Ciona intestinalis), the presence of kf-1  
is represented by a triangle as only fragmented amino acid sequences  
have been found similar to those of KF-1. This is probably due to  
an incomplete determination of genomic sequences. Detailed data  
on which this illustration is essentially based are given in (A), (B), and (C). Frontiers in Neuroscience  www.frontiersin.org  May 2009 |  Volume 3  |  Issue 1  |  20
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Figure 2 | Immunostaining of Xenopus KF-1 tagged with the Myc epitope 
and PSα or PSβ co-expressed in COS-1 cells. (A) Proteins were stained  
with anti-Myc antibody probed with rhodamin conjugated anti-mouse IgG  
for KF-1 (red) and anti-PSα (Xenopus PS1 homologue) probed with ﬂuorescein 
isothiocyanate (FITC) conjugated to anti-rabbit IgG for PSα (green). Images  
of ‘anti Myc (KF-1)’ and ‘anti PSα’ are merged (‘merge’). (B) The same as 
(A) except PSβ (Xenopus PS2 homologue) was used instead of PSα. KF-1  
is co-localized with either PSα or PSβ as indicated in yellow or orange (‘merge’).
Table 1 | Behavioral phenotypes of kf-1–/– mice compared to the behavioral phenotypes of kf-1+/+ littermates.
Tests  Measurements  Phenotypesa
General health examination  Whisker, coat, reﬂexes  =
Physical test  Body temperature  =
  Body weight  =
  Wire hanging time  ↑
  Grip strength  =
  Auditory capacity  =
Light/dark transition test  Anxiety  ↑
Open field test  Exploratory locomotion  =
Elevated plus maze test  Anxiety  ↑
Hot plate test  Pain sensitivity (latency time)  =
Social interaction test  Total duration of contacts  =
  Number of contacts  =
  Total duration of active contacts  =
  Mean duration/contact  =
  Distance traveled  =
Rotarod test  Motor coordination  =
Prepulse inhibition (PPI) test  Sensorimotor gating  ↑
Porsol forced swimming test  Immobility time (behavioral despair)  =
T-maze test  Spatial working memory  =
Cued and contextual fear conditioning test  Immediate freezing during conditioning phase  ↑
  Contextual testing conducted after conditioning  =
  Cued test with altered context  =
Tail suspension test  Immobility time (behavioral despair)  =
The testing order is from the top to the bottom of this table. Further details are presented in Tsujimura et al. (2008). a =, no significant difference; ↑, increased in 
kf-1−/− compared to kf-1+/+. The raw data of the results are available at https://behav.hmro.med.kyoto-u.ac.jp/.Frontiers in Neuroscience  www.frontiersin.org  May 2009 |  Volume 3  |  Issue 1  |  21
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transitions: p = 0.0392) (Tsujimura et al., 2008). 
Consistently, the mice also show ‘timidity-like’ 
responses  under  stressful  situations,  such  as 
prolonged wire-  hanging time, enhanced imme-
diate freezing with an aversive foot shock, and 
decreased locomotor activity at heights (Table 1 
and Tsujimura et al., 2008). As significant differ-
ences are not observed in body weight and grip 
strength, and in general exploratory locomotion, 
the ‘timidity-like’ responses are likely to be related 
to psychological but not physical alterations in 
kf-1−/− mice. This implies that KF-1 plays a role in 
emotional control by suppressing anxiety at least 
in mice. In this context, it is of particular inter-
est to note that a number of SNPs are reported 
in the coding and non-coding exonic regions of 
human kf-1 according to the NCBI’s SNP data-
base,  and  some  are  supposed  to  substantially 
modulate KF-1 activity in homozygous or dual 
heterozygous carriers; for example, rs35921467 
resulting in a frame shift at amino acid position 
180, rs17857046 and rs17853383 in critical amino 
acid substitutions (S to P and P to H) at 251 and 
502, respectively, and rs11695337 in a termination 
codon at 626.
As KF-1 is an E3 ubiquitin ligase located on 
ER, KF-1 may be responsible for conducting the 
ERAD pathway, in which some factors promoting 
anxiety may be targeted. Therefore, the absence or 
reduction of KF-1 activity may result in ‘enhanced 
anxiety’ by increasing putative anxiety promot-
ers (Figure 3A). Regarding serotonergic metabo-
lisms, it is not clear at the moment whether or how 
the ERAD pathway directed by KF-1 is associ-
ated with the serotonergic pathway, and it has to 
be elucidated in future. However, KF-1’s targets 
for proteasomal degradation should be neither 
the serotonin receptor (5-HT1A) nor the trans-
porter (5-HTT), because a lack of these proteins 
increases  anxiety-like  behaviors  (Heisler  et al., 
1998; Holmes et al., 2003).
Kf-1 and parKIn aS er-baSed e3 
ubIquItIn lIgaSeS
Ubiquitination  plays  an  essential  regulatory 
role in all critical eukaryotic cellular processes. 
Proteasomal  degradation  through  the  ERAD 
pathway is not an exception. It has been well estab-
lished that these processes play an important role 
in a variety of human somatic diseases, ranging 
from cancer, viral infection, diabetes, and inflam-
mation to muscle wastage and neurodegenera-
tive disorders (see Kostova et al., 2007; Petroski, 
2008). However, there are no reports on the ani-
mal specific ubiquitin ligase, which is responsi-
ble for emotional control or mental   disorders. 
Figure 3 | Schematic representation of the anxiety suppressor model 
through the ERAD pathway. (A) When KF-1 is absent or decreases, the 
putative anxiety promoter will be increased on the ER, resulting in ‘enhanced 
anxiety’. (B) When KF-1 is present or increases, the putative anxiety 
promoter will be degraded or lost due to 26S proteasomal degradation through 
the KF-1 mediating ERAD pathway, resulting in ‘anxiolysis’. ‘Ub’ represents  
the ubiquitin molecule. ‘E1’, ‘E2’, and ‘E3’ represent the ubiquitin-activating 
enzyme, ubiquitin-conjugating enzyme, and ubiquitin ligase, respectively.
SNP
DNA sequence variation, called single 
nucleotide polymorphism, occurring 
on a single nucleotide in the genome 
among individual members of a species 
or between paired chromosomes within 
an individual. ‘SNP (pronounced snip)’ 
was defined initially as that with  
a minor allele frequency of ≥1%, but 
this definition is rather artificial and not 
meaningful.
Ubiquitination
Ubiquitination (or ubiquityation)  
is the post-translational tagging 
reaction mediated by E3 ubiquitin 
ligase to a protein with one or more 
highly conserved peptide molecules 
called ‘ubiquitin’ consisting of 76  
amino acids. Ubiquitination targets  
the substrate protein for proteasomal 
degradation.Frontiers in Neuroscience  www.frontiersin.org  May 2009 |  Volume 3  |  Issue 1  |  22
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Concerning   neurodegenerative disorders, Parkin, 
another ER-ubiquitin ligase, plays a key role in 
preventing  the  degeneration  of  dopaminergic 
neurons  in  Parkinson’s  disease (PD). A  reces-
sive mutation in parkin is responsible for the 
neurodegenerative disorder known as the auto-
somal recessive juvenile form of Parkinsonism, 
the most common form of familial PD (Kitada 
et al., 1998). Human parkin with 12 exons ranging 
over approximately 1.5 Mb is located on chro-
mosome 6q25.2.27, and encodes an E3 ubiquitin 
ligase, consisting of 465 amino acids, with two 
RING finger motifs. Parkin substrates have been 
identified  being  degraded  through  the  ERAD 
pathway, such as Pael-R, CDCrel-1, α-Syn, and 
synphilin-1 (Yang et al., 2003). The accumula-
tion of these proteins in dopaminergic neurons 
leads to ER stress-induced apoptosis, resulting 
in PD (see von Coelln et al., 2004). Promoting 
their degradation would aid PD patients by pre-
venting neurodegeneration. In fact, the neuronal 
synthesis of the Parkin substrate Pael-R has been 
shown to cause a loss of dopaminergic cells in 
transgenic Drosophila models. The co-expression 
of parkin results in the degradation of Pael-R 
and  nearly  completely  blocks  neurodegenera-
tion, whereas interfering with the function of 
endogenous Drosophila Parkin promotes Pael-R 
accumulation and augments its toxicity (Yang 
et al., 2003). Hence, the over-expression of parkin 
has emerged as a powerful approach to PD with 
complementary effects to approaches described 
for the use of neurotrophic factors against PD 
(Ulusoy and Kirik, 2008). An analogy could be 
made by having such Drosophila models to study 
the role of KF-1 in anxiety/depression. However, 
the analogy may not be feasible as no evidence 
is available for the involvement of neuronal cell 
death in anxiety/depression, and kf-1 is absent in 
Drosophila (Figure 1D). It should be noted that 
kf-1
−/− mice have increased PPI values (Table 1), 
which implies that at least one of the KF-1 target 
proteins is involved in regulation of sensorimo-
tor gating. In such cases, over-expression of kf-1 
might cause serious side effects as the PPI values 
are  usually  reduced  in  schizophrenic  patients.     
Despite this, one cannot rule out the possibility 
of kf-1 up-regulation as an anxiolytic/antidepres-
sant treatment.
Instead, kf-1−/− mice provide a powerful tool 
for some pharmacological approaches to anxiety/
depression. For example, by using the mice, one 
can identify the putative anxiety promoters that 
are degraded through the ERAD pathway medi-
ated by KF-1 and are responsible for the sensi-
tivity to potential signs of danger or to stressful 
situations (Figures 3A,B). KF-1 substrates acting 
as anxiety promoter may be found by the com-
puted differential screening in 2-dimensional gel 
electrophoresis (see Marengo et al., 2008) of cell 
homogenates derived from the frontal cortex or 
hippocampus of kf-1−/− and kf-1+/+ mice. As the 
Figure 4 | A circuitry presentation of the anxiety suppressor model by the up-regulation of kf-1 expression.  
The circuitry model was constructed by considering the fear extinction neural model (Sotres-Bayon et al., 2006).  
The anxiolytic pathway after kf-1 up-regulation is incorporated into the model.
PPI
Prepulse inhibition (PPI) is a 
neurological phenomenon where  
a weaker pre-stimulus inhibits  
the reaction of animals to a subsequent 
strong startling stimulus.
Sensorimotor gating
The brain’s ability to filter  
out the unnecessary information.Frontiers in Neuroscience  www.frontiersin.org  May 2009 |  Volume 3  |  Issue 1  |  23
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expression of kf-1 is   up-regulated in the frontal 
cortex  and  hippocampus  after  antidepressant 
treatments, it is likely that the anxiolytic/anti-
depressive  effect  of  KF-1  functions  primarily 
in these tissues and that their inhibitory signals 
are transmitted to the amygdala to prevent the 
manifestation of anxiety or fear (Figure 4). This 
proposal may be highly hypothetical and hence 
has to be   elucidated in future studies. To conclude, 
examining  kf-1−/−  mice  in  a  simple  light/dark 
transition test is an effective method of screening 
novel anxiolytic/  antidepressant drugs that inhibit 
the putative anxiety promoters.
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